Phase I and IIa Trial for Assessment of Safety, Immunogenicity (Phase Ia) and Efficacy (Phase IIa) Against Sporozoite Challenge of P. Falciparum Pre-Erythrocytic and Blood Stage Malaria Vaccine Candidate
Latest Information Update: 10 Feb 2022
At a glance
- Drugs Malaria vaccine (Primary) ; Aluminium hydroxide
- Indications Malaria
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Acronyms PEBS-POC1
- Sponsors Vac4All
- 01 Jun 2012 New trial record